See What HealthDay Can Do For You
Contact Us

Gestational Diabetes Provides a Chance to Educate Patients

Women with gestational diabetes have higher risk of developing type 2 diabetes later

TUESDAY, May 26 (HealthDay News) -- Because women with gestational diabetes are at increased risk of subsequently developing type 2 diabetes, increasing awareness among both physicians and patients about the risk can be used as an opportunity to promote behavior that may delay or prevent the disease, according to a study published in the May 23 issue of The Lancet.

Leanne Bellamy, of Northwick Park Hospital in London, and colleagues conducted a meta-analysis of 20 studies in which women were diagnosed with type 2 diabetes after gestational diabetes. The studies comprised 675,455 women, and there were 10,859 type 2 diabetic events.

The relative risk of developing type 2 diabetes was 7.43 times higher among women who had gestational diabetes compared to those with a normoglycemic pregnancy, the researchers discovered, and in the largest study of 659,164 women and 9,502 type 2 diabetes cases, the relative risk was 12.6.

"A history of gestational diabetes therefore provides a low-cost, natural screening test for future type 2 diabetes. Resolution of the metabolic changes after pregnancy could provide an opportunity to test the effectiveness of interventions for the primary prevention of type 2 diabetes with changes in diet and lifestyle, and the introduction of treatments to prevent or delay the onset of type 2 diabetes," the authors write. "These interventions might have an important effect on women's health."

One co-author reported financial ties to the pharmaceutical industry.

Full Text (subscription or payment may be required)

Physician's Briefing


HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.